Cannabis Law Report

DECEMBER 27, 2019

A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. The trials focus on correlations between treatments and outcomes in real-world settings.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

SpeedWeed

MAY 17, 2021

They are trained on holistic remedies and are encouraged to help customers find alternative treatments that pair well with the medicine they are taking over the counter or through prescriptions. . Some of the popular treatments that are available so far are melatonin, lavender, aromatherapy treatments, elderberry, and zinc.

CBD 52

CBD Seed-To-Sale Supply Chain Treatment 52

Cannabis Law Report

DECEMBER 15, 2021

A number of clinical trials have been investigating the potential of psychedelics in mental health treatment. Following research findings here and abroad, the application sought to have the drugs used as part of psychotherapy treatment for mental illnesses, depression and post-traumatic stress disorder.

Clinical Trials 52

Clinical Trials Conditions Supply Chain Environment 52

Cannabis Law Report

MAY 3, 2022

Whilst we received the best quality care modern medicine can offer and palliative care I became acutely aware of the potential hurdles people face with their preferred treatment(s) of choice. I staunchly believe in the “right to choose” ones treatment and bodily autonomy. Freedom of determination. Freedom of information.

Supply Chain 52

Supply Chain Access Treatment Patients 52

MMJ Recs

FEBRUARY 23, 2024

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Patients benefit from a broad spectrum of cannabis products addressing various medical conditions.

Marijuana 52

Marijuana Dispensary Research and Development Supply Chain 52

Cannabis Law Report

NOVEMBER 18, 2019

The impetus behind this movement is multifaceted but at the forefront is Walter de Benedetto, a patient with rheumatoid arthritis potentially facing prison for growing nine marijuana plants to assuage his pain. Access to cannabis-based medicine would be promoted to patients suffering from symptoms that respond favourably to cannabinoids.

Supply Chain 77

Supply Chain Chronic Pain Consumption Cultivation 77

Cannabis Law Report

JULY 13, 2019

Here’s the report… Therapeutic cannabis may soon be legally available in France to hundreds of thousands of patients suffering from serious pain caused by illness. According to patient groups, somewhere between 300,000 and 1 million patients could be eligible to its use.

Supply Chain 40

Supply Chain Pharmaceutical Patients Agriculture 40

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

MAY 23, 2019

Jim McClendon who thinks medical cannabis patients should just sort out their own supply chains in the black market. When Matt Murphy, one of the two radio hosts, suggested that cannabis was already in his district and that meeting with cancer patients helped by medical marijuana, McClendon was nonplussed.

Supply Chain 40

Supply Chain Recreational Patients Treatment 40

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

Cannabis Law Report

DECEMBER 6, 2021

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Jeff W. Dr. Jacobs was responsible for building the CMC team and supply chain / operations at Ardelyx. Jacobs, Ph.D.

Research and Development 52

Research and Development Supply Chain Clinical Trials Medicine 52

NewsMunchies

JULY 30, 2018

After nearly three years of delays, limitations, and patient struggles surrounding Florida’s medical marijuana program, its head honcho – Christian Bax – is stepping down. He has been criticized by legislators, patients, and dispensaries due to the state’s restrictive and intensely competitive medical marijuana market.

Marijuana 47

Marijuana Supply Chain Patients Edibles 47

SpeedWeed

FEBRUARY 28, 2021

TheraTrue is committed to using extensive research and cutting-edge technology to provide vertically integrated production facilities designed to safely deliver medical grade cannabis products to patients in Georgia and Virginia. For media inquiries, contacts or questions, please email [email protected]. . Background. TheraTrue, Inc.

Research and Development 52

Research and Development Supply Chain Patients Pharmaceutical 52

Cannabis Law Report

JANUARY 24, 2022

The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. Growing adoption of medical marijuana for treatment of chronic diseases. In countries, such as Canada and the U.S.,

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

CannaMD

APRIL 15, 2020

To learn more about medical marijuana treatment center (MMTC) delivery services, please see: Florida Dispensaries: COVID-19 Policies. This designation permits them to continue to provide important services to patients who rely on them. There are several million state-licensed medical cannabis patients in America.

Policy 55

Policy Patients Dispensary Banking 55

SpeedWeed

AUGUST 4, 2021

For the first time, he was a patient and not a criminal. They presented case studies about patients who have had incredible success from their cannabis treatments. I want to be a part of the change that sees patients become able to access quality cannabis medicines and to change lives. day/night, temperature, humidity).

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

MMJ Recs

MAY 1, 2020

In fact, many medical marijuana patients have stocked up on supplies as many people have stocked up on toilet paper and other important household goods. Understandably, they’re afraid of a disruption in the supply chain that would keep them from accessing the MMJ they use for treatment.

Law 66

Law Marijuana Dispensary Supply Chain 66

Cannabis Law Report

NOVEMBER 26, 2021

Through FloVaria, Flora will provide distribution, supply chain, and marketing support of KaLaya products in Colombia, Mexico, and other LATAM countries, while Avaria will initially supply the finished product to FloVaria. KaLaya Observational Study on Pain Relief. felt pain relief within one minute.

Wellness and Beauty 52

Wellness and Beauty Supply Chain Research and Development Events 52

Cannabis Law Report

SEPTEMBER 16, 2022

The program is a “limited license” regime, under which a set number of vertically integrated “Medical Marijuana Treatment Centers” are licensed to cultivate, process, and dispense cannabis to qualified patients. Arkansas dispensaries began serving qualified patients in 2019. In 2021, more than $1.2 Code § 16-12-191.

Law 52

Law Programs Cultivation Dispensary 52

Cannabis Law Report

SEPTEMBER 1, 2021

Of note, the number of Independent Testing Laboratories in the Commonwealth increased from three to five in 2021, which the Commission hopes will increase the product supply that is tested, approved, and available to consumers and patients.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

NOVEMBER 14, 2019

Since early this year, distribution of a narcotic cannabis production license has been restricted to government organizations, universities and hospitals, all for the purpose of research and treating patients and none for commercial. There are simply no local pharma-grade cannabis medicine supply chains available here in Thailand.

Legislation 55

Legislation Pharmaceutical Medicine Supply Chain 55

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. ” The Releaf app allows users to journal and track what cannabis products they are using and what effects they have in order to build an evidence-based treatment regime. .

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

FEBRUARY 15, 2019

Under strict manufacturing and pharmaceutical standards, 400 grammes of Bedrocan cannabis and 400 grammes of Bedica grown by Dutch biopharmaceutical firm, Bedrocan, was imported by IPS Specials following prescriptions issued for chronic pain at a cost of £695 per private patient. (In It has 15 wholly owned subsidiary companies.

History 56

History Legalization Chronic Pain Pharmaceutical 56

SpeedWeed

AUGUST 16, 2021

After receiving her PhD from the University of California at Berkeley, she was named Director of Research and Patient Services at Berkeley Patients Group, one of the oldest dispensaries in the country. . With Personal Plants, a main goal is to change the stereotype, while educating people about what it means to be a cannabis patient.

Chronic Pain 52

Chronic Pain Dispensary Supply Chain THC 52

Cannabis Law Report

DECEMBER 21, 2021

Engaging in these markets required Dalrada’s perseverance to overcome continual supply chain delays created by the pandemic that is now in its second year. Ignite products are ecologically responsible and do not require additional wastewater treatment. The renewable clean energy market is projected to reach $1,977.6

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

NOVEMBER 9, 2021

As an institution dedicated to diagnosing and treating serious blood diseases and with the ability to pursue investigational medicines from development to manufacture and clinical trial for patients who have exhausted all approved treatment options, having a cost-effective and rapid production chain is integral to ÚHKT’s mission.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

The Cannigma

MAY 7, 2021

There were somewhat of a, I want to say grey, but it wasn’t the pharma routes for patients in the US who wanted to get certain products, you know? While these high standards are certainly good practice, it doesn’t adequately consider that cannabis is a plant, which means it does not have the same stability as chemical compounds.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

AUGUST 19, 2019

To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. Further, entities in the CBPM’s supply chain must be licensed by the Home Office and MHRA. The Regulations define a CBPM as a preparation or product that. (a)

Environment 45

Environment Food Seed-To-Sale Medicine 45

Veriheal

AUGUST 31, 2021

She provides clear strategies for teaching healthcare professionals how to improve their proficiency and cultural competency for caring for medical marijuana patients. Essay Summary: VeChain is a blockchain technology built to simplify supply chain management. Benjamin Sanchez. School: Northwestern University. Qamar Saitovski.

Research and Development 108

Research and Development Supply Chain Programs Education 108

Veriheal

MARCH 23, 2022

” There are currently ketamine clinics operating all across the United States; however, many health insurance companies do not cover what many still consider to be alternative treatments. Enthea is expected to expand its psychedelic treatment options to include other substances, such as psilocybin and MDMA , pending FDA approval.

Therapy 82

Therapy Treatment Supply Chain Pharmaceutical 82

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. In addition, SciSparc had established its supply chain infrastructure for the manufacturing and delivering of the SCI-110 drug. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Additionally, there were several instances in which cepharanthine displayed growth inhibition which was comparable or superior to current gold standard treatments, including colorectal, liver and skin cancers.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

CannaTech

JUNE 30, 2019

Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case. Maximum prescription of 40g/month.

Patients 40

Patients Oil Epilepsy Strains 40

Cannabis Law Report

MARCH 6, 2020

Europe is on the forefront of pharmaceutical development in the growing market for cannabinoid receptor target therapeutics which should bring further attention to our efforts in moving KLS-13019 forward for the treatment of neuropathic pain and other CNS disorders associated with neuroinflammation,” said Dean Petkanas , CEO of Kannalife.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

The Cannigma

FEBRUARY 3, 2022

of babies, to doing robotic surgery, and now, helping geriatric patients navigate cannabis medicine. It is a challenging landscape to navigate and Dr. Bone is just doing phenomenal work helping patients. I usually tell my patients, take this edible, get your paring knife out, cut it into four pieces. MB: I agree with you 100%.

Wellness and Beauty 109

Wellness and Beauty Patients Medicine Cannabis 109

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Thus, a wide application scope has led to an increased product demand for the treatment of various chronic conditions.

Recreational 95

Recreational Hemp THC Legalization 95